期刊文献+

治疗房颤的新型药物屈奈达隆

Dronedarone:a novel agent for treatment of atrial fibrillation
原文传递
导出
摘要 房颤是最常见的心律失常病症,其发病率随着年龄的增长而提高。胺碘酮(Amiodarone)是治疗房颤的最有效药物之一,但因其严重心外不良反应,而使其应用大大受限。法国Sanofi-Aventis公司历经20多年研发了胺碘酮类似物屈奈达隆(dronedarone),并于2009年7月1日获美国FDA批准上市。文中对屈奈达隆的化学合成、药理学、药动学、临床试验研究进展做一综述。 Atrial fibrillation is the most common type of cardiac arrhythmias,and its prevalence increases with age.Amiodarone is the most effective drug for treatment of atrial fibrillation;however,the usage of this drug was extensively limited due to its severe extra-cardiac side-effects.Dronedarone,the analogue of amiodarone,has been developed for over two decades by Sanofi-Aventis,a French company,and approved by the American Food and Drug Administration(FDA) on 1st July,2009.The chemical synthesis,pharmacology,pharmacokinetics,and clinical trials of dronedarone were reviewed in this paper.
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第6期481-486,513,共7页 Chinese Journal of New Drugs
基金 国家科技部"863"计划项目(2007AA02Z307)
关键词 心律失常 房颤 屈奈达隆 化学合成 临床试验 cardiac arrhythmia atrial fibrillation dronedarone chemical synthesis clinical trials
  • 相关文献

参考文献27

  • 1ZHOU ZQ, HU DY, CHEN J, et al. An epidemiological survey of atrial fibrillation in China [ J ]. Chin J lnt Med, 2004,43 (7) : 491 - 494.
  • 2ROY D, TALAJIC M, NATTEL S, et al. Rhythm'control versus rate control for atrial fibrillation and heart failure [ J ]. N Engl J Med, 2008, 358(25): 2667-2677.
  • 3NATTEL S, OPIE LH, Controversies in atrial fibrillation [ J]. Lancet, 2006, 367(9506): 262-272.
  • 4EHRLICH JR, NATTEL S. Novel approaches for pharmacological management of atrial fibrillation [ J 1. Drugs, 2009, 69 (7) : 757 - 774.
  • 5KATHOFER S, THOMAS D, KARLE CA. The novel antiarrhythmic drug dronedarone: comparison with amiodarone [ J ]. Cardiovasc Drug Rev, 2005, 23(3): 217-230.
  • 6GUTMAN A, NISNEVICH G, YUDOVITCH L. Process for the preparation of dronedarone: US, 7312345 (B2) [ P]. 2007 - 12 -25.
  • 7ZIMETBAUM PJ. Dronedarone for atrial fibrillation-an odyssey [J]. NEngl JMed, 2009, 360(18): 1811 -1813.
  • 8SCHMITT J, EHRLICH JR, HOHNLOSER SH. New antiarrhythmic drugs for the treatment of atrial fibrillation[ J]. Herz, 2008, 33(8): 562-567.
  • 9RIDLEY JM, MILNES JT, WITCHEL H J, et al. High affinityHERG K ( + ) channel blockade by the antiarrhythmie agent dronedarone : resistance to mutations of the S6 residues Y652 and F656 [ J ]. Biochem Biophys Res Commun, 2004, 325 (3) : 883 - 891.
  • 10SUN W, CHEN FH, FARDARD E, et al. Acute effects of dronedarone on the potassium currents in human atrial cells [ J ]. J Am Cull Cardiul, 2002, 39( Suppl 1 ) : S105.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部